Phosphorylation of human estrogen receptor-beta at serine 105 inhibits breast cancer cell migration and invasion
- 1 July 2012
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 358 (1) , 27-35
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Cracking the Estrogen Receptor's Posttranslational Code in Breast TumorsEndocrine Reviews, 2011
- Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G2 cell-cycle arrestCell Death & Differentiation, 2010
- Comprehensive Identification and Modified-Site Mapping of S-Nitrosylated Targets in Prostate Epithelial CellsPLOS ONE, 2010
- Phosphoproteomics by mass spectrometry: insights, implications, applications and limitationsExpert Review of Proteomics, 2009
- Systematic Mapping of Posttranslational Modifications in Human Estrogen Receptor-α with Emphasis on Novel Phosphorylation SitesMolecular & Cellular Proteomics, 2009
- Immunohistochemical validation of multiple phospho-specific epitopes for estrogen receptor α (ERα) in tissue microarrays of ERα positive human breast carcinomasBreast Cancer Research and Treatment, 2008
- Phosphorylation of estrogen receptor alpha, serine residue 305 enhances activityMolecular and Cellular Endocrinology, 2008
- A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cellsOncogene, 2007
- Estrogen receptor (ER)-β isoforms: A key to understanding ER-β signalingProceedings of the National Academy of Sciences of the United States of America, 2006
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896